Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons.

Péterfi Z, Urbán GM, Papp OI, Németh B, Monyer H, Szabó G, Erdélyi F, Mackie K, Freund TF, Hájos N, Katona I.

J Neurosci. 2012 Oct 10;32(41):14448-63. doi: 10.1523/JNEUROSCI.1676-12.2012.

2.

Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals.

Nyilas R, Dudok B, Urbán GM, Mackie K, Watanabe M, Cravatt BF, Freund TF, Katona I.

J Neurosci. 2008 Jan 30;28(5):1058-63. doi: 10.1523/JNEUROSCI.5102-07.2008.

3.

Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.

Mátyás F, Urbán GM, Watanabe M, Mackie K, Zimmer A, Freund TF, Katona I.

Neuropharmacology. 2008 Jan;54(1):95-107. Epub 2007 Jun 22.

4.

Hardwiring the brain: endocannabinoids shape neuronal connectivity.

Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urbán GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T.

Science. 2007 May 25;316(5828):1212-6.

5.

Molecular composition of the endocannabinoid system at glutamatergic synapses.

Katona I, Urbán GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF.

J Neurosci. 2006 May 24;26(21):5628-37.

Supplemental Content

Loading ...
Support Center